Skip to main content
. 2022 Feb 18;11(2):811–820. doi: 10.1007/s40123-022-00480-4
Why carry out this study?
Pediatric uveitis has a high rate of ocular complications that can result in permanent vision loss.
Subtenon triamcinolone acetate (STA) injections are commonly used in the outpatient clinic setting to treat uveitis and macular edema in adults, but the outpatient use in pediatric patients has not been reported.
We hypothesized that STA with topical anesthesia alone can be a safe and effective treatment option in pediatric uveitis.
What was learned from the study?
Treatment with STA with topical anesthesia resulted in improvement of inflammation for 85.4% of eyes and resolution of macular edema in 77.8% at 3 months post treatment.
At 6 months after STA, incidence of ocular hypertension was 12.5% and no new cataracts developed.
STA with topical anesthesia can be a useful option for short-term management of pediatric uveitis.